Person: Vial, Pablo
Loading...
Email Address
Birth Date
3 results
¿Qué estás buscando?
Search Results
Now showing 1 - 3 of 3
Publication Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study(2023) Hormazabal, Juan; Nuñez-Franz, Loreto; Rubilar, Paola; Apablaza, Mauricio; Vial Cox, María Cecilia; Cortes Salinas, Lina Jimena; González, Natalia; Vial, Pablo; Said, Macarena; Gonzalez Wiedmaier, Claudia; Olivares, Kathya; Aguilera, Ximena; Ramírez-Santana, MurielThe study compared immunity to the original SARS-CoV-2 virus (Wuhan) and the Omicron variant using neutralizing antibodies (NAbs), that provide a good approximation of protective immunity. The results might help determine immunization strategies. Design and methods: Unlike previous studies, we analyzed NAbs in a random sample of 110 IgG positive sera from individuals who participated in a population-based seroprevalence transversal study, carried out in May 2022 in two Chilean cities, a country with high vaccination coverage. Results: Our findings indicate that 98.2% of individuals had NAbs against Wuhan, 65.5% against Omicron, and 32.7% tested positive for Wuhan but not Omicron. Factors influencing protective immunity included a prior natural infection and the number of vaccines received. NAbs titers against the original virus were high, demonstrating vaccine effectiveness in the population. However, the level of antibodies decreased when measuring NAbs against Omicron, particularly among older individuals, indicating a decline in vaccine protection. Previous COVID-19 episodes acted as a natural booster, increasing NAbs titers against both virus strains. Conclusions: Protective immunity against the original Wuhan SARS-CoV-2 virus is reduced when compared to Omicron variant. Updating vaccine to target emerging variants and continued monitoring of effectiveness at the population level are necessary.Publication Post-COVID-19 condition: a sex-based analysis of clinical and laboratory trends(2024) Delfino, Carlos; Poli Harlowe, María Cecilia; Vial Cox, María Cecilia; Vial, Pablo; Martínez, Gonzalo; Riviotta, Amy; Arbat, Catalina; Mac-Guire, Nicole; Hoppe, Josefina; Carvajal, Cristóbal; Munoz Venturelli, PaulaBackground and aim: Post-COVID-19 condition (PCC) encompasses long-lasting symptoms in individuals with COVID-19 and is estimated to affect between 31-67% of patients, with women being more commonly affected. No definitive biomarkers have emerged in the acute stage that can help predict the onset of PCC, therefore we aimed at describing sex-disaggregated data of PCC patients from a local cohort and explore potential acute predictors of PCC and neurologic PCC. Methods: A local cohort of consecutive patients admitted with COVID-19 diagnosis between June 2020 and July 2021 were registered, and clinical and laboratory data were recorded. Only those <65 years, discharged alive and followed up at 6 and 12 months after admission were considered in these analyses. Multivariable logistic regression analysis was performed to explore variables associated with PCC (STATA v 18.0). Results: From 130 patients in the cohort, 104 were contacted: 30% were women, median age of 42 years. At 6 months, 71 (68%) reported PCC symptoms. Women exhibited a higher prevalence of any PCC symptom (87 vs. 60%, p = 0.007), lower ferritin (p = 0.001) and procalcitonin (p = 0.021) and higher TNF levels (p = 0.042) in the acute phase compared to men. Being women was independently associated to 7.60 (95% CI 1.27-45.18, p = 0.026) higher risk for PCC. Moreover, women had lower return to normal activities 6 and 12 months. Conclusion: Our findings highlight the lasting impact of COVID-19, particularly in young women, emphasising the need for tailored post-COVID care. The lower ferritin levels in women are an intriguing observation, warranting further research. The study argues for comprehensive strategies that address sex-specific challenges in recovery from COVID-19.Publication Overcoming Health Inequities: Spatial Analysis of Seroprevalence and Vaccination Against COVID-19 in Chile(2024) Muriel Ramírez-Santana , Juan Hormazábal, Luis Canales, Pablo Vial, and Ximena Aguilera; Correa, Juan; Núñez Franz, Loreto; Apablaza, Mauricio; Rubilar, Paola; Vial Cox, María Cecilia; Cortes, Lina Jimena; Hormazabal, Juan; Canales, Luis; Vial, Pablo; Aguilera, XimenaBackground: In unequal economies, the spread of the first waves of the COVID-19 was usually associated withlow socioeconomic status of individuals and their families. Chile exemplified this. By mid-2020, Chile had one ofthe highest SARS-CoV-2 infection rates in the world predominantly in poorer areas. A year later, the countrylaunched a universal vaccination campaign based on the national strategy of immunization established in1975. By 2022, Chile presented one of the highest COVID-19 vaccination coverages globally, reaching 94.3%of the population with the primary scheme by the end of 2022.Objective: This study analyzes the spatial distribution of SARS-CoV-2 seroprevalence at the beginning of the pan-demic (2020) compared with the seroprevalence after 2 years of ongoing epidemic and COVID-19 vaccinationcampaigns (2022).Methods: Two population-based random samples of individuals aged 7 years and older from two Chilean citieswere studied. Utilizing an enzyme-linked immunosorbent assay test, IgG antibodies were measured in serum of1061 participants in 2020, and 853 in 2022.Results: Using the Global Moran’s Index, the seroprevalence distribution pattern for the year 2020 showed clus-tering in the two cities. Conversely, seroprevalence and vaccinations were homogeneously distributed in 2022.These results show the success of the vaccination campaign in Chile, not only in coverage but also because itwidely reached all individuals.Conclusions: The uptake of this preventive measure is high, regardless of the social and economic factors,achieving broad population immunity. The extensive deployment of the primary health care network contrib-uted to reducing health inequities and promoting to universal health access.